These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 16212924)
21. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007 [TBL] [Abstract][Full Text] [Related]
22. In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. Murillo O; Dubrot J; Palazón A; Arina A; Azpilikueta A; Alfaro C; Solano S; Ochoa MC; Berasain C; Gabari I; Pérez-Gracia JL; Berraondo P; Hervás-Stubbs S; Melero I Eur J Immunol; 2009 Sep; 39(9):2424-36. PubMed ID: 19662633 [TBL] [Abstract][Full Text] [Related]
23. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. Langstein J; Michel J; Fritsche J; Kreutz M; Andreesen R; Schwarz H J Immunol; 1998 Mar; 160(5):2488-94. PubMed ID: 9498794 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2. Reali C; Curto M; Sogos V; Scintu F; Pauly S; Schwarz H; Gremo F J Neurosci Res; 2003 Oct; 74(1):67-73. PubMed ID: 13130507 [TBL] [Abstract][Full Text] [Related]
29. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. Flórido M; Borges M; Yagita H; Appelberg R J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035 [TBL] [Abstract][Full Text] [Related]
30. CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Lippert U; Zachmann K; Ferrari DM; Schwarz H; Brunner E; Mahbub-Ul Latif AH; Neumann C; Soruri A Eur J Immunol; 2008 Apr; 38(4):1024-32. PubMed ID: 18395851 [TBL] [Abstract][Full Text] [Related]
31. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Palazón A; Teijeira A; Martínez-Forero I; Hervás-Stubbs S; Roncal C; Peñuelas I; Dubrot J; Morales-Kastresana A; Pérez-Gracia JL; Ochoa MC; Ochoa-Callejero L; Martínez A; Luque A; Dinchuk J; Rouzaut A; Jure-Kunkel M; Melero I Cancer Res; 2011 Feb; 71(3):801-11. PubMed ID: 21266358 [TBL] [Abstract][Full Text] [Related]
32. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Kocak E; Lute K; Chang X; May KF; Exten KR; Zhang H; Abdessalam SF; Lehman AM; Jarjoura D; Zheng P; Liu Y Cancer Res; 2006 Jul; 66(14):7276-84. PubMed ID: 16849577 [TBL] [Abstract][Full Text] [Related]
33. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer. Lynch DH Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008 [TBL] [Abstract][Full Text] [Related]
34. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Tirapu I; Arina A; Mazzolini G; Duarte M; Alfaro C; Feijoo E; Qian C; Chen L; Prieto J; Melero I Int J Cancer; 2004 May; 110(1):51-60. PubMed ID: 15054868 [TBL] [Abstract][Full Text] [Related]
35. Immunotherapy targeting 4-1BB and its ligand. Vinay DS; Kwon BS Int J Hematol; 2006 Jan; 83(1):23-8. PubMed ID: 16443548 [TBL] [Abstract][Full Text] [Related]
36. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282 [TBL] [Abstract][Full Text] [Related]
37. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650 [TBL] [Abstract][Full Text] [Related]